Connecticut SB 231: AN ACT CONCERNING WORKERS' COMPENSATION BENEFITS FOR CERTAIN MENTAL OR EMOTIONAL IMPAIRMENTS SUFFERED BY EMERGENCY MEDICAL SERVICES PERSONNEL, DEPARTMENT OF CORRECTION EMPLOYEES AND DISPATCHERS.
Status: Joint Favorable Substitute (as of 2020-03-10)
State: Connecticut · Session: 2020 · Bill: SB 231
Subjects: Correctional institution employees, Public safety telecommunicators, Workers' compensation, Emergency medical responders
Sponsors: Anwar, Saud, Borer, Dorinda, Boyd, Patrick S., Haskell, Will, Hayes, Rick L., Linehan, Liz, Looney, Martin M., Osten, Catherine A., Porter, Robyn A., Rochelle, Kara, Turco, Gary A., Winkler, Michael A.
Bill Text
LCO 1 of 8 General Assembly Substitute Bill No. 231 February Session, 2026 AN ACT CONCERNING THE DEPARTMENT OF CONSUMER PROTECTION'S RECOMMENDATIONS REGARDING CANNABIS REGULATION AND ELECTRONIC NICOTINE DELIVERY SYSTEM DEALER REGISTRATION. Be it enacted by the Senate and House of Representatives in General Assembly convened: Section 1. Section 21a-408w of the general statutes is repealed and the 1 following is substituted in lieu thereof (Effective from passage): 2 (a) Each cannabis establishment shall submit marijuana samples to a 3 cannabis testing laboratory for testing [as set forth in subsection (b) of 4 this section] in accordance with the laboratory testing standards 5 established in the policies and procedures issued, and final regulations 6 adopted, by the Commissioner of Consumer Protection pursuant to 7 section 21a-421j. 8 [(b) (1) A cannabis testing laboratory shall test each marijuana sample 9 submitted pursuant to subsection (a) of this section (A) for 10 microbiological contaminants, mycotoxins, heavy metals and pesticide 11 chemical residue, and (B) for purposes of conducting an active 12 ingredient analysis, if applicable. 13 (2) Microbiological contaminant testing conducted pursuant to 14 subparagraph (A) of subdivision (1) of this subsection shall include, but 15 not be limited to, microbiological contaminant testing for Aspergillus 16 Raised Bill No. 231 LCO 2 of 8 species as set forth by the Department of Consumer Protection and 17 posted on the department's Internet web site. 18 (c) When conducting microbiological testing as set forth in subsection 19 (b) of this section, the marijuana sample shall be tested by using (1) a 20 molecular method that (A) includes quantitative polymerase chain 21 reaction, (B) is certified for identifying microbiological DNA, and (C) is 22 approved by (i) the Association of Official Analytical Collaboration 23 International, or (ii) a comparable national or international standards 24 organization designated by the Commissioner of Consumer Protection, 25 or (2) an alternative testing method approved by the Department of 26 Consumer Protection and posted on the department's Internet web site.] 27 [(d)] (b) If a marijuana sample [does not pass] fails the testing [set 28 forth in] required under subsection [(b)] (a) of this section, the cannabis 29 establishment that submitted [such] the failing marijuana sample to the 30 cannabis testing laboratory shall, not later than sixty days after the date 31 of such failed testing, either: 32 (1) Repeat the testing [as set forth in subsections] required under 33 subsection (a) [and (b)] of this section on the marijuana batch from 34 which such marijuana sample was taken, in a form and manner 35 approved by the Department of Consumer Protection. If all repeated 36 testing yields satisfactory results, the marijuana batch from which the 37 marijuana samples were taken shall be released for sale; or 38 (2) If such cannabis establishment submits to the Commissioner of 39 Consumer Protection a remediation plan that is sufficient to ensure 40 public health and safety, and the commissioner approves such 41 remediation plan, remediate the marijuana batch from which such 42 marijuana sample was taken and repeat all testing [as set forth in 43 subsections] required under subsection (a) [and (b)] of this section on 44 such remediated marijuana batch, in a form and manner approved by 45 the Department of Consumer Protection. If all repeated testing yields 46 satisfactory results, the marijuana batch from which the marijuana 47 samples were taken shall be released for sale. [; or] 48 Raised Bill No. 231 LCO 3 of 8 [(3)] (c) If [such] a cannabis establishment does not comply with 49 [subdivision (1) or (2) of this] subsection (b) of this section, or if any 50 subsequent laboratory testing does not yield satisfactory results for the 51 testing [set forth in subsections] required under subsection (a) [and (b)] 52 of this section, the cannabis establishment shall dispose of the entire 53 marijuana batch from which the marijuana sample was taken in 54 accordance with procedures established by the Commissioner of 55 Consumer Protection, as published on the Department of Consumer 56 Protection's Internet web site. The cannabis establishment shall 57 complete such disposal not later than sixty days after the later of (1) the 58 date of the failed testing performed pursuant to subsection (a) of this 59 section, (2) the date of the failed repeated testing performed pursuant to 60 subsection (b) of this section, or (3) if no repeated testing is performed 61 pursuant to subsection (b) of this section, expiration of the sixty-day 62 period established in subsection (b) of this section for the performance 63 of such repeated testing. During such sixty-day period, the cannabis 64 establishment may submit a written request to the department, in a form 65 and manner prescribed by the commissioner, to extend such sixty-day 66 period. The com
View Connecticut SB 231 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.